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A complete understanding of the molecular mechanisms involved in the formation and repair of the central nervous system
myelin sheath requires an unambiguous identification and isolation of in vivo-differentiated myelin-forming cells. In order
to develop a novel tool for the analysis of in vivo-differentiated oligodendrocytes, we generated transgenic mice expressing
a red-shifted variant of the green fluorescent protein under the control of the proteolipid protein promoter. We demonstrate
here that green fluorescent protein-derived fluorescence in the central nervous system of 9-day- to 7-week-old mice is
restricted to mature oligodendrocytes, as determined by its spatiotemporal appearance and by both immunocytochemical
and electrophysiological criteria. Green fluorescent protein-positive oligodendrocytes could easily be visualized in live and
fixed tissue. Furthermore, we show that this convenient and reliable identification now allows detailed physiological
analyses of differentiated oligodendrocytes in situ. In addition, we developed a novel tissue culture system for in
ivo-differentiated oligodendrocytes. Initial data using this system indicate that, for oligodendrocytes isolated after
ifferentiation in vivo, as yet unidentified factors secreted by astrocytes are necessary for survival and/or reappearance of a
mature phenotype in culture. © 2000 Academic Press
Key Words: GFP; differentiated oligodendrocyte; patch clamp; primary culture; live cell imaging.a
g
O
a
t
t
d
p
(
p
t
r
t
d
d
c
aINTRODUCTION
A better understanding of the molecular mechanisms by
which the oligodendrocyte forms and maintains the central
nervous system (CNS) myelin sheath likely advances the
development of strategies for repair of the injured sheath in
demyelinating diseases, such as multiple sclerosis (Duncan
et al., 1997; Franklin and Blakemore, 1997; Lassmann et al.,
1997). Oligodendrocyte differentiation has been investi-
gated extensively in cell culture systems. While these
studies have provided excellent insights into the biology of
the early stages of the oligodendrocyte lineage (Noble and
Wolswijk, 1992; Barres and Raff, 1994), investigations on
the biology of mature oligodendrocytes are far less well
1 Present address: Department of Anatomy, Virginia Common-
wealth University, Richmond, VA.
2 Present address: Department of Physiology and Neurobiology,
gniversity of Connecticut, Storrs, CT.
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All rights of reproduction in any form reserved.dvanced. The identification of antibodies to surface anti-
ens expressed by differentiated oligodendrocytes, O4 and
1/GC (Sommer and Schachner, 1981), allowed refined
nalyses of oligodendrocytes at different stages of differen-
iation. However, it was subsequently demonstrated that
he O4 antibody recognizes additionally the “proligoden-
roblast” antigen present on the surface of oligodendrocyte
rogenitors (Bansal et al., 1992) and that galactocerebroside
GC) is detectable on the surface of adult oligodendrocyte
rogenitor cells (Shi et al., 1998). Furthermore, investiga-
ions of oligodendrocytes differentiated in culture might
eveal functional characteristics that are different from
hose existing in situ in the brain, and there are likely
ifferences between the initial differentiation of the oligo-
endrocyte and remyelination in the adult.
In order to provide unequivocal identification and purifi-
ation of in vivo-differentiated oligodendrocytes, we gener-
ted transgenic mice expressing a red-shifted variant of the
reen fluorescent protein (GFP) under the control of the
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260 Fuss et al.proteolipid protein (PLP) promoter (PLP-GFP mice). PLP is a
gene that in the CNS is specifically expressed in differenti-
ating and mature oligodendrocytes. Using a promoter con-
struct that contains all the information required for spatio-
temporal expression similar to PLP, we previously
generated transgenic mice that express a PLP–b-
galactosidase fusion protein (Wight et al., 1993). Although
hese mice provide a valuable source of tagged oligodendro-
ytes, the requirement of an enzymatic reaction or highly
pecific antibodies precludes their use for visualization in
ive tissue or purification of oligodendrocytes from cell
uspensions. In contrast, GFP yields a bright green fluores-
ence in the absence of cofactors and in a species-
ndependent manner (Chalfie et al., 1994; Tsien, 1998), and
it has been used to specifically label certain cell types of the
CNS. For example, Zhuo et al. (1997) generated transgenic
animals that exclusively express GFP in astrocytes, which
permits in vivo visualization of these cells. Wang et al.
(1998) used GFP expression driven by the neuronal T a1
ubulin promoter for transfection studies in order to isolate
euronal precursor cells.
In the current study, transgenic mice (PLP-GFP mice) in
hich mature oligodendrocytes are specifically labeled by
FP-derived fluorescence have been generated. Electro-
hysiological analyses in these mice show that this cell-
ype-specific fluorescent label provides an excellent tool for
etailed physiological characterization of differentiated oli-
odendrocytes in situ. Furthermore, these mice are a novel
ource for the isolation of in vivo-differentiated oligoden-
rocytes and, therefore, for a unique tissue culture system
hat now allows the characterization of potentially novel
actors necessary for survival and/or maturation of in vivo
erminally differentiated oligodendrocytes. Ultimately, the
se of the transgenic PLP-GFP mice permits a variety of
ew approaches for the analysis of functional characteris-
ics and regenerative capacities of mature oligodendrocytes.
MATERIALS AND METHODS
Generation of Transgenic Mice
For the generation of the transgenic PLP-GFP construct, the
PLP-LacZ construct used by Wight et al. (1993) was modified as
follows: The ATG start codon for the PLP protein in exon 1 was
mutated using the Sculptor in vitro mutagenesis system (Amer-
sham, Arlington Heights, IL), which is based on the phosphorothio-
ate technique (Sayers et al., 1992; Taylor et al., 1985). The sequence
around the ATG was changed from GAC ATG to CTC GAG (C
AGA GTG CCA AAC CTC GAG GTG AGT TTC). This mutation
created an additional XhoI site for better analysis and allowed
protein translation to start at the appropriate ATG in the GFP
mRNA, while keeping PLP exon/intron consensus sequences that
are known to be necessary for proper splicing. An additional ATG
located at the beginning of exon 2 was mutated using the USE
mutagenesis kit (Pharmacia, Piscataway, NJ) which is based on the
unique-site elimination mutagenesis procedure (Deng and Nick-
oloff, 1992). The target mutagenic primer oligonucleotide (G TTA
GAG TGT GCC GCA TGC TGT CTG GTA G) introduced an SphI t
Copyright © 2000 by Academic Press. All rightsite, which was used to delete the sequences coding for the first 13
amino acids of PLP and to insert polylinker sequences that in-
cluded the unique restriction sites SfiI, SmaI, EcoRV, NotI, and
SacII. Subsequently, the SV40 poly(A) sequence derived from
pcDNA3 (Invitrogen, Carlsbad, CA) (nt 2933–3128) was introduced
as a SmaI–NotI fragment (amplified by PCR to introduce 59 and 39
restriction sites). Further unique restrictions sites (such as AscI and
PacI) were introduced by insertion of the SmaI–HindIII fragment
derived from the polylinker region of the vector pNEB193 (New
England Biolabs, Inc., Beverly, MA). The sequence coding for GFP
was isolated from the vector phGFP-S65T (Clontech Laboratories,
Inc., Palo Alto, CA) as a 734-bp HindIII–NotI fragment. To enable
insertion of the GFP sequences into the restriction sites AscI and
PacI, a modified version of the vector pNEB193 was generated.
Briefly, after deletion of the sequences located between EcoRI and
SmaI, as well as XbaI and HindIII, the following restriction sites
were inserted between the AscI and the PacI sites: HindIII, PstI,
SmaI, NotI, and XhoI. After subcloning into this intermediate
vector, the GFP sequences could be inserted as a 770-bp AscI–PacI
fragment.
For injection into pronuclei of B6CBA fertilized oocytes, an
approximately 12-kb ApaI–SacII fragment (see Fig. 1) was used.
Oocytes were transferred into oviducts of pseudopregnant mice
(Hogan et al., 1994), and the resulting potential founder animals
were tested by Southern blot analysis (Sambrook et al., 1989).
Genomic DNA was prepared from tail biopsies using the QIAamp
tissue kit (Qiagen Inc., Valencia, CA). One male founder was
identified and bred to C57/B6 females to generate a homozygous
line.
Northern Blot Analysis
RNA was isolated from different tissues of wild-type and trans-
genic PLP-GFP mice using the single-step RNA isolation method
described by Chomczynski and Sacchi (1987). Ten micrograms of
total RNA were separated on 1.2% agarose gels containing 2.2 M
formaldehyde. RNA was transferred to MagnaGraph nylon mem-
branes (Micron Separations, Inc., Westboro, MA) and hybridized
sequentially with the complete cDNAs coding for GFP (phGFP-
S65T; Clontech Laboratories, Inc.), PLP (LeVine et al., 1990; Sorg et
al., 1987), and cyclophilin (Danielson et al., 1988) at 42°C. DNA
fragments were labeled with [a-32P]dCTP using the High Prime
labeling kit according to the manufacturer’s instructions (Boehr-
inger Mannheim, Indianapolis, IN). Analysis was performed by
autoradiography and phosphorimaging techniques (Molecular Dy-
namics, Sunnyvale, CA). After each analysis, blots were stripped
using two 30-min incubations in 5 mM Tris–HCl, pH 7.5, 0.2 mM
EDTA, pH 8.0, 0.13 Denhardt’s, 0.05% pyrophosphate at 65°C and
then reused for further hybridizations.
Western Blot Analysis
Tissues from 23-day-old transgenic PLP-GFP mice were ho-
mogenized in 50 mM Tris–HCl, pH 7.5, 2 mM EGTA in the
presence of protease inhibitors (1 mg/ml leupeptin (Sigma, St.
ouis, MO), 1 mg/ml Pefabloc (Boehringer Mannheim)) using a
olytron homogenizer (Brinkmann Instruments, Inc, Westbury,
Y). Protein concentrations were determined by the bicincho-
inic acid protein assay (Sigma). Homogenates were diluted 1:2
n sample buffer (2% SDS, 20% glycerol, 100 mM DTT, 50 mM
ris, pH 6.8, 0.1% bromphenol blue) and proteins were dena-ured by boiling. Forty micrograms of each protein sample was
s of reproduction in any form reserved.
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261GFP-Labeled Differentiated Oligodendrocytesresolved on 4 –20% SDS/polyacrylamide gels (Novex, San Diego,
CA). Purified recombinant GFP-S65T protein (Clontech Labora-
tories, Inc.) was used as positive control. Proteins were trans-
ferred to Immobilon-P PVDF membranes (Millipore Corp., Bed-
ford, MA) in Tris/glycine/methanol buffer at 350 mA for 2 h
(Towbin et al., 1979). Membranes were blocked in 5% fat-free
milk powder in TBS-T (10 mM Tris–HCl, pH 7.5, 0.15 M NaCl,
0.2% Tween 20) and incubated overnight at 4°C with polyclonal
anti-GFP antibodies (Clontech Laboratories, Inc.) or polyclonal
anti-actin antibodies (Sigma) at a dilution of 1:1000. Bound
antibodies were detected using horseradish peroxidase (HRP)-
conjugated anti-rabbit IgG antibodies (Amersham) in combina-
tion with the enhanced chemiluminescence detection system
(ECL Plus; Amersham). For stripping and reprobing membranes
were incubated for 30 min at 70°C in 100 mM b-mercapto-
ethanol, 2% SDS, 62.5 mM Tris–HCl, pH 6.7, according to the
manufacturer’s instructions (ECL Plus; Amersham).
Immunocytochemistry
For immunocytochemistry of tissue sections, 23-day-old and
adult (more than 6-week-old) transgenic mice were used. Non-
transgenic littermates were used as controls. Transgenic and
nontransgenic mice were perfused with 4% paraformaldehyde in
PBS (pH 7.4), brains were removed and postfixed in the same
fixative for 4 –12 h at 4°C. Subsequently, Vibratome sections of
75–100 mm thickness were cut under ice-cold PBS and stored in
BS at 4°C. Free-floating sections were incubated for 4 h at room
emperature (RT) in PBS containing 0.1% (v/v) Triton X-100 and
0% (v/v) nonimmune goat serum (Life Technologies, Grand
sland, NY). Sections were washed in PBS and incubated in PBS
ontaining 0.01% Triton X-100 and 1% nonimmune goat serum
or 24 h at 4°C with monoclonal antibodies against 29,39-cyclic
nucleotide 39-phosphodiesterase (CNP) (clone SMI 91; Stern-
berger Monoclonals, Inc., Baltimore, MD), Adenomatous pol-
yposis coli protein (clone CC1; Calbiochem–Novabiochem
Corp., San Diego, CA), glial fibrillary acidic protein (GFAP)
(Sigma), neuronal nuclei (NeuN) (Chemicon International, Inc.,
Temecula, CA), and polyclonal antibodies that were generated
against the 35 amino acids specific for the PLP protein (Asotra
and Macklin, 1993). After sections were washed in PBS, bound
primary antibodies were detected by incubation with Texas
red-coupled secondary antibodies (Jackson ImmunoResearch,
West Grove, PA) for 4 – 8 h at RT. Sections were mounted in
Vectashield mounting medium (Vector Laboratories, Inc., Bur-
lingame, CA) and analyzed by a confocal laser scanning micro-
scope (Aristoplan; Leica, Deerfield, IL). Confocal images repre-
sent optical sections of 1–2 mm.
For immunocytochemistry of live primary cultures, nonspecific
antibody-binding sites were blocked by incubation in Dulbecco’s
modified Eagle medium (DMEM) (Life Technologies) containing
10% fetal calf serum (FCS) (Life Technologies) for 10 min at RT.
Subsequently, cells were incubated with anti-GC antibodies
(Boehringer Mannheim) diluted 1:100 in DMEM/FCS. After 1 h,
cells were washed in DMEM/FCS and incubated for 30 min in
1:100 diluted Texas red-coupled secondary antibodies (Jackson
ImmunoResearch). Fluorescent signals were analyzed by a confocal
laser scanning microscope (Aristoplan; Leica). Confocal images
represent series of optical sections of 1 mm.
Copyright © 2000 by Academic Press. All rightPreparation of Corpus Callosum Slices and
Electrophysiological Recordings
Brain slices were prepared as described previously (Berger et al.,
1991). Briefly, 7-week-old transgenic mice were sacrificed by cer-
vical dislocation. Forebrains were quickly dissected out, washed in
artificial cerebrospinal solution at 8–10°C, and cut into 150-mm-
thick frontal-oriented slices using a Vibratome (FTB; Plano, Mar-
burg, Germany). The corpus callosum was cut parallel to its axonal
fascicles. Slices were transferred to a nylon net in bathing solution
and kept at RT. For electrophysiological recordings, slices were
placed in a chamber that was mounted on the stage of an upright
confocal laser-scanning microscope (CLSM) (Sarastro 2000; Mo-
lecular Dynamics; Axioscope; Zeiss, Oberkochen, Germany). Brain
slices were fixed within the chamber using a U-shaped platinum
wire with a grid of nylon threads (Edwards et al., 1989). The
chamber was continuously perfused with oxygenated bathing so-
lution. Cell somata within the corpus callosum slices were visible
in normal water immersion optics and could be approached by the
patch electrode. GFP-expressing cells were selected under green
epifluorescence (fluorescein filter set; Zeiss). Cell somata had a
clear, dark membrane surface and were located 10–30 mm beneath
the surface of the slice. Positive pressure was applied to the
recording pipette while it was lowered to the slice under micro-
scopic control. The cellular debris was blown aside and the tip
could be placed onto the surface of the cell soma. Using the
patch-clamp technique in whole-cell recording configuration,
membrane currents were analyzed after activation by a series of de-
and hyperpolarizing voltage steps (from 2160 to 120 mV in 10-mV
increments) (Hamill et al., 1981). Current signals were amplified
with conventional electronics (EPC-7 amplifier; List Electronics,
Darmstadt, Germany), filtered at 3 kHz, and sampled at 5 kHz by
an interface (WinTida; HEKA, Lambrecht, Germany) connected to
a personal computer system, which also served as a stimulus
generator. After patch-clamp recording, cells were hyperpolarized
to 2150 mV to facilitate the dialysis of the fluorescent dye Lucifer
yellow from the pipette solution into cellular processes. CLSM
images were recorded before and after patch-clamp recording (laser
excitation at 488 nm) and represent optical sections of 1 mm.
Solutions and electrodes. A standard bathing solution (134.0
mM NaCl, 2.5 mM KCl, 2.0 mM CaCl2, 1.3 mM MgCl2, 1.25 mM
K2HPO4, 26.0 mM NaHCO3, 10.0 mM D-glucose, pH 7.4; with a
total K1 concentration of 5 mM) was used. The solution was gassed
with a mixture of 95% O2 and 5% CO2. The internal pipette
olution had the following composition: 130 mM KCl, 0.5 mM
aCl2, 3.0 mM MgCl2, 5.0 mM EGTA, 3.0 mM Lucifer yellow, 10.0
mM Hepes, pH 7.2. Recordings were carried out at room tempera-
ture. Recording pipettes were made from borosilicate capillaries
(Hilgenberg, Malsfeld, Germany). The open resistance of these
patch pipettes was 4–5 MV.
Fluorescence-Activated Cell Sorting (FACS)
Brains and spinal cords were removed from 3- to 4-week-old
transgenic PLP-GFP and wild-type mice. Meninges were removed
by adhesion onto sterile Whatman No. 1 filter paper (Whatman,
Hilsboro, OR). Tissues were minced into small pieces using a
sterile razor blade and incubated for 30 min at 37°C in Hanks’
balanced salt solution (HBSS) containing 13 pancreatin (Life Tech-
nologies) and 0.25% trypsin (Life Technologies). Subsequently,
s of reproduction in any form reserved.
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262 Fuss et al.tissue pieces were triturated gently in DMEM containing 10% FCS
(DMEM/FCS). Cells were collected by centrifugation, incubated in
the presence of DNase (0.5 mg/ml; Sigma) in HBSS for 5 min at
37°C, and again collected by centrifugation. For analytical flow
cytometry, cells were resuspended in DMEM/FCS (0.5–1 3 106
cells/250 ml) and stained with antibodies to O4 (Sommer and
chachner, 1981) and phycoerythrin (PE)-coupled secondary anti-
odies (Vector Laboratories, Inc.). The percentage of double O4- and
FP-positive cells was determined by two-color analysis using a
ACScan flow cytometer, equipped with an argon laser tuned at
88 nm, in combination with the CELLQuest software (Becton
ickinson, Bedford, MA). For detection of GFP-S65T and PE-
erived fluorescence 530- and 585-nm band-pass filters were used,
espectively. Debris was excluded from analysis by electronic
ating.
For purification of mature oligodendrocytes, tissue homogenates
ere prepared as described above. Subsequently, cells were centri-
uged at 1200 rpm in a tabletop centrifuge (Sorvall TC6; Sorvall,
nc., Newtown, CT) for 5 min and resuspended in PBS. The
issociated cells were mixed with 90% Percoll (Sigma) in a 3:2
atio. Continuous density gradients were formed by centrifugation
SS34 rotor; Sorvall, Inc.; 10,000 rpm, 20 min). The upper myelin
ayer was removed, the intermediate layers containing oligoden-
roglial cells were collected, and the lower, erythrocyte-containing
ayer was discarded (Kim et al., 1984). After treatment with DNase,
ells were resuspended in DMEM/25% FCS and GFP-expressing
ells were purified using a FACS Vantage flow cytometer (Becton–
ickinson, Bedford, MA; supported through a gift from the W. M.
eck Foundation). Fluorescence emission was read with a 530/30
and-pass filter and debris was eliminated by adjusting the forward
nd side scatter. In a typical experiment, approximately 1 3 104 live
GFP-positive cells per animal could be isolated for subsequent
culture studies.
Primary Cultures
Cells purified by flow cytometry were plated onto poly-L-
lysine (30 mg/ml; Sigma)-coated coverslips. Cells (1–2.5 3 104)
ere plated in 50-ml drops until cells had adhered to the
overslip (approximately 1 h). Cells were cultured in DMEM/
0% FCS or DMEM containing 13 N2 supplement (Life Tech-
ologies) and 3,39,59-triiodo-L-thyronine (T3) (10 ng/ml) (DMEM/
2/T3). In addition, cells were grown in either of the above
edia after conditioning by type I astrocytes. After 24 h, 50%
olume of DMEM/N2/T3 was added to the astrocyte-
onditioned medium to a final volume of 33% to ensure the
resence of factors that are known to be essential for oligoden-
rocyte survival (Barres et al., 1993) and for morphological and
unctional maturation of postmitotic oligodendrocytes (Baas et
l., 1997). Cells were analyzed under phase-contrast illumina-
ion and by immunocytochemistry.
Primary cultures of rat cortical type I astrocytes were obtained
y the modified differential adhesion method (McCarthy and
eVellis, 1980; Stanimirovic et al., 1997). After reaching conflu-
ncy, astrocytes were cultured for 2 to 3 days in DMEM/FCS or
MEM/N2/T3 to obtain astrocyte-conditioned medium. Astro-
ytes grown in DMEM/N2/T3 did not appear morphologically
ifferent from those grown in DMEM/FCS for at least 3 days in
ulture. P
Copyright © 2000 by Academic Press. All rightRESULTS
Transgenic PLP-GFP Mice Were Generated That
Express GFP mRNA and Protein in a Pattern
Similar to Endogenous PLP
In order to develop a novel tool that allows reliable
analysis and isolation of in vivo-differentiated oligoden-
drocytes, we generated transgenic mice expressing GFP-
S65T under the control of the PLP promoter (PLP-GFP
mice). We chose the GFP-S65T mutant because of its
red-shifted excitation maximum, which allows the use of
standard FITC excitation– emission filter sets for analysis
(Delagrave et al., 1995; Heim et al., 1995). For the
generation of the transgenic construct we modified
the one used by Wight et al. (1993) (Fig. 1). In the orig-
inal PLP-LacZ construct, the sequence coding for
b-galactosidase was inserted in frame with the sequence
oding for the first 13 amino acids of PLP. Since
b-galactosidase activity derived from this fusion protein
as localized predominantly in the myelin, it was sug-
ested that the N-terminal 13 amino acids of PLP were
ufficient to target a protein to the myelin membrane
Wight et al., 1993). For translation/translocation of the
ransgenically expressed GFP to occur independently of
FIG. 1. Generation of the transgenic construct. Similar to the
transgenic PLP-LacZ construct (Wight et al., 1993), we used 2.4 kb
of the 59 flanking DNA, exon 1, and intron 1 of the mouse PLP gene
for the transgenic PLP-GFP-S65T construct. To allow production of
the transgenic GFP to occur independently of PLP-derived amino
acid sequences, the ATG in PLP exon 1 was mutated to GAG and
PLP-coding sequences in exon 2 were deleted, allowing translation
to start 39 of PLP intron 1. For transcription termination, a SV40
poly(A) signal sequence (horizontally striped box) was introduced 39
of the cDNA sequence encoding GFP (GFP box). White boxes
represent vector sequences, black and diagonally striped boxes
symbolize exon and intron regions of the mouse PLP gene, respec-
tively.LP-derived amino acids, the ATG in exon 1 was mutated
s of reproduction in any form reserved.
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263GFP-Labeled Differentiated Oligodendrocytesto GAG and the sequences coding for the first 13 amino
acids of PLP were deleted, while keeping the exon–intron
boundaries intact. The inclusion of intron 1 in the
promoter construct appeared necessary since recent stud-
ies demonstrated the presence of regulatory elements
within intron 1 (Wight and Dobretsova, 1997). After
insertion of the sequences coding for the GFP-S65T
variant, the ApaI–SacII fragment of the PLP-GFP-S65T
construct (Fig. 1) was used for injection into fertilized
oocytes. Of 14 potential founder transgenic mice 1 male
animal was proven positive for insertion of the transgene
into the genome. This founder animal was used to
generate a homozygous line, progeny of which were
further analyzed. Homozygous animals showed no appar-
ent pathological phenotype up to 9 months of age.
Northern blot analyses demonstrated that the develop-
mental and tissue-specific expression of the transgene was
consistent with that of the endogenous PLP gene (Fig. 2). No
expression of GFP mRNA was detectable in wild-type
animals (lane wt in Fig. 2Aa). Low levels of GFP and PLP
mRNA were detected in brains of 1- and 5-day-old trans-
genic mice (lanes P1 and P5 in Figs. 2Aa and 2Ab). Expres-
sion of both GFP and PLP mRNAs showed a clear peak at
postnatal day 21 (P21 in Figs. 2Aa and 2Ab) which corre-
sponds to a peak in myelination. With age, however, there
was a greater decrease in the level of GFP mRNA compared
FIG. 2. Analysis of GFP expression by Northern and Western bl
23-day-old PLP-GFP mice [spinal cord (spC), brain (B), thymus (Th
brains of PLP-GFP mice at different developmental ages [postnat
21-day-old wild-type mice (wt). Northern blots were sequentially h
b and e), and cyclophilin (c). The cyclophilin-specific bands in c serv
8S rRNA in f is shown as loading control for d and e. Northern bl
pC to S), and 5 days (e; lane Te). The molecular weights of the ma
otal protein of different tissues from 23-day-old PLP-GFP mice an
ecombinant GFP-S65T protein were analyzed. Membranes wer
nti-actin antibodies (b). Bound antibodies were detected with HRP
olecular weights of the protein standards are given at the right mto PLP mRNA levels (compare lanes P32 in Figs. 2Aa and b
Copyright © 2000 by Academic Press. All rightAb). GFP mRNA was found predominantly in spinal cord
nd brain, with low levels detectable in testis (Fig. 2Ad).
he same tissue-specific expression pattern was found for
LP mRNA, although the mRNA levels in spinal cord and
rain were significantly higher for PLP than for GFP (com-
are exposure times for Figs. 2Aa and 2Ab or Figs. 2Ad and
Ae). The size of the GFP mRNA was approximately 3.5 kb,
hereas the predicted molecular weight of this mRNA was
.1 kb. RT-PCR analyses of the coding region of the trans-
enic mRNA generated a fragment of the expected size,
hich was amplified using a primer pair specific for the PLP
9-UTR and SV40 poly(A) sequences (not shown). Thus,
here appeared to be a 39 extension of the transgenic
LP-GFP mRNA beyond the SV40 poly(A) sequence present
n the transgenic construct. We concluded that a poly(A)
ignal sequence derived from genomic sequences 39 of the
ransgenic insertion site was used during transcription. In
rder to ensure that this mRNA alteration had no conse-
uence on protein expression from the transgene, i.e., that
orrect GFP expression occurred in these mice, we per-
ormed Western blot analyses (Fig. 2B). In spinal cord, brain,
nd testis a protein with an apparent molecular weight of 27
Da was detected (lanes spC, B, and Te in Fig. 2Ba). This
ize corresponds to the size of recombinant GFP-S65T
rotein (lanes GFP in Fig. 2Ba). Altogether, these data
uggested that in the CNS the transgenic GFP is expressed
n (A), 10 mg of total RNA was analyzed from different tissues of
rt (H), lung (Lu), liver (Li), kidney (K), spleen (S), testis (Te)], from
ys 1 (P1), 5 (P5), 12 (P12), 21 (P21), 32 (P32)], and from brains of
dized with 32P-labeled DNA probes specific for GFP (a and d), PLP
loading controls for a and b, whereas the ethidium bromide-stained
ere exposed to film for 2 days (a), 24 h (b), 5 days (d), 3 h (e; lanes
RNAs are given at the right margins in base pairs. In (B), 40 mg of
ng (GFP, left lane), as well as 0.1 ng (GFP, right lane), of purified
ubated with polyclonal anti-GFP antibodies (a) and polyclonal
pled secondary antibodies and enhanced chemiluminescence. The
n in kDa.ots. I
), hea
al da
ybri
e as
ots w
rker
d 1
e inc
-couy oligodendrocytes.
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264 Fuss et al.GFP Fluorescently Labels Oligodendrocytes, Which
Can Be Visualized in Fixed and Live Tissue
For the visualization of GFP-positive cells in fixed and
live tissue, we chose the following CNS areas, due to their
relatively simple morphology: cerebellum, hippocampus,
corpus callosum, and optic nerve. We did not perform a
detailed analysis of GFP expression in the peripheral ner-
vous system (PNS), since, despite the activity of the PLP
promoter in the PNS (Wight et al., 1993), we could not
directly detect cells fluorescently labeled by their GFP
expression in teased fibers of the sciatic nerve. We, there-
fore, concluded that GFP expression levels in the PNS are
too low to result in a directly detectable fluorescent label in
situ in the transgenic PLP-GFP mice.
FIG. 3. Analysis of GFP expression by confocal imaging using a 1
1/1) and transgene-negative (2/2) adult cerebellum were viewed
FP). In addition, oligodendrocytes and myelin were labeled usin
ed-coupled secondary antibodies and laser excitation at 568 nm (
atter areas (wm), with scattered cells present in the inner granula
evoid of GFP-positive cells. Arrows in lower left and right indica
isualized by GFP-derived fluorescence in the cell body and nucleAnalysis of Vibratome sections of adult cerebellum, using
Copyright © 2000 by Academic Press. All rightonfocal imaging techniques, revealed GFP-positive cell
odies in the inner white matter tracts (Fig. 3). In addition,
ells were detectable in a scattered distribution within the
nner granular layer, but absent from the Purkinje cell and
uter molecular layers. For a more accurate localization of
ligodendrocytes and their myelin membranes, monoclonal
ntibodies specific for CNP, a myelin-associated enzyme
Braun et al., 1990), were used. As expected, cells positive
for GFP could be identified in areas that were positive for
CNP (Fig. 3, 1/1 CNP and 1/1 GFP). GFP-derived fluores-
cence was confined to cell bodies and nuclei. This predomi-
nant localization of GFP-derived fluorescence within cell
bodies and nuclei appears to be a general feature of the
unmodified GFP protein (Moriyoshi et al., 1996). However,
op) or 633 (bottom) objective. Vibratome sections of homozygous
laser excitation at 488 nm to visualize GFP (2/2, 1/1, and 1/1
noclonal antibodies specific for CNP in combination with Texas
CNP). GFP-positive cells were localized predominantly in white
r (g). The Purkinje cell layer (p) and outer molecular layer (m) were
example of a typical CNP-positive oligodendrocyte that could be
cale bars: 50 mm, top; 10 mm, bottom.63 (t
with
g mo
1/1
r laye
te ana precise colocalization of cell bodies double positive for
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265GFP-Labeled Differentiated OligodendrocytesGFP and CNP in myelin-rich CNS areas was not easily
obtained, due to a more uniform myelin-associated CNP
staining (Fig. 3, 1/1 CNP). Occasionally single cells could
e distinguished at the edges of white matter tracts where
he overall CNP stain was less, with clear GFP–positive cell
odies/nuclei and CNP-positive cytoplasm and processes
arrows in lower left and right of Fig. 3). To assess the
dentity of GFP-positive cells more accurately, we used
ntibodies that specifically label oligodendrocyte cell bod-
es (clone CC1) (Bhat et al., 1996), processes and somata of
astrocytes (anti-GFAP), and neuronal nuclei (anti-NeuN)
(Mullen et al., 1992) for double-labeling experiments (Fig.
4A). As a representative CNS region, we analyzed hip-
pocampal areas, including the white matter tracts sur-
rounding it (alveus and corpus callosum). These studies
clearly demonstrated that neither astrocytes nor neurons
were labeled by GFP (Fig. 4A, GFP/GFAP and GFP/NeuN).
In general, over 95% of the GFP-positive cells were also
CC1 positive. In confocal overlays, however, some strongly
GFP-labeled cells appeared CC1 negative, due to low levels
of CC1 expression (not shown). Since CC1 expression in
oligodendrocytes is not very well characterized for the
different developmental stages of the oligodendrocyte lin-
eage, the few CC1-negative, GFP-positive cells may repre-
sent an oligodendrocyte differentiation stage that is nega-
tive for the CC1 antigen, but positive for PLP-GFP
expression. Additionally, CC1-positive, GFP-negative cells,
particularly visible in areas with low density or apparent
absence of oligodendrocyte cell bodies (cortical layers and
stratum oriens of the hippocampal formation in Fig. 4A),
most likely result from the weak staining by CC1 reported
for subpopulations of astrocytes (Bhat et al., 1996).
The above data confirmed that GFP in the CNS of
PLP-GFP mice is expressed exclusively by oligodendro-
cytes. However, although PLP is considered a myelin-
specific protein (Yoshida and Colman, 1996), DM-20, an
alternatively spliced product of the PLP gene, was shown to
be expressed during embryonic development of the nervous
system (Peyron et al., 1997; Timsit et al., 1992; Yu et al.,
1994). Furthermore, detailed analysis of PLP and DM-20
expression at different stages of the oligodendrocyte lineage
revealed that DM-20 is expressed in premyelinating oligo-
dendrocytes, whereas PLP expression is specific for myeli-
nating oligodendrocytes (Trapp et al., 1997). In order to
evaluate whether in situ visualization of GFP-positive oli-
godendrocytes in the postnatal CNS of PLP-GFP mice is
confined to mature oligodendrocytes or additionally allows
the identification of DM-20-expressing, premyelinating oli-
godendrocytes, we performed immunocytochemical analy-
ses using an antibody that recognizes an epitope unique to
PLP (Asotra and Macklin, 1993). We analyzed cells at the
leading edge of myelination in the cerebral cortex at post-
natal day 14, because of the presence of a relative high
number of premyelinating oligodendrocytes. We found that
all GFP-positive cells in this area colocalize with PLP-
immunoreactivity (Fig. 4B). These data clearly demon-
strated that in the postnatal (14-day and older) CNS of the
Copyright © 2000 by Academic Press. All rightPLP-GFP mice GFP-derived fluorescence is directly detect-
able only in terminally differentiated and myelinating oli-
godendrocytes. The earliest stages of the oligodendrocyte
lineage that, therefore, can be isolated and directly visual-
ized by their GFP expression are cells that already started to
myelinate axons. These results do not exclude GFP from
occurring in premyelinating oligodendrocytes. However,
levels of expression appear to be extremely low, and there-
fore, the presumably generated fluorescent label in these
cells remains below detection limits for direct visualization
in situ.
Overall, the above data demonstrated that GFP-positive,
in vivo terminally differentiated oligodendrocytes could
easily be visualized in fixed tissue. However, one of the
main advantages in using GFP lies in the possibility of
visualizing GFP-positive cells in live tissues. We studied
the optic nerve in whole mount as a model to localize live
GFP-positive cells. The optic nerve represents one of the
simplest parts of the CNS, which contains primarily cell
bodies of astrocytes, oligodendrocytes, and axons of retinal
ganglion cells. During development, oligodendrocyte pro-
genitor cells migrate into the nerve in a gradient from the
chiasm to the retina. Subsequent differentiation occurs in a
similar fashion (Colello et al., 1995). Consistent with this
developmental program, GFP-positive cells could be de-
tected only close to the chiasm in optic nerves dissected out
of 6-day-old transgenic PLP-GFP mice, whereas in optic
nerves of 32-day-old mice, GFP-positive cells were located
over the whole length of the nerve (Fig. 5). In the most
proximal (retinal) part of the optic nerve, where axons
remain unmyelinated (Bartsch et al., 1994), there were no
detectable GFP-positive cells even at postnatal day 32.
These data demonstrated that GFP-positive oligodendro-
cytes can be visualized in live tissue from transgenic
PLP-GFP mice. Furthermore, the restricted localization of
GFP-positive cells in postnatal day 6 optic nerve, a devel-
opmental time point at which oligodendrocyte progenitor
cells can be found throughout the length of the nerve,
further confirmed that GFP expression in the PLP-GFP
mice labels differentiated oligodendrocytes rather than
oligodendrocyte precursor cells.
GFP-Positive Cells Express Symmetrical, Passive,
Inward, and Outward Membrane Currents
Characteristic of Mature Oligodendrocytes
Since the expression of specific ion channels by cells of
the oligodendrocyte lineage correlates with differentiation
stage, further evidence for the identity of the GFP-positive
cells as mature oligodendrocytes could be obtained by
electrophysiological methods. Brain slices from 7-week-old
transgenic mice, which contained myelinated corpus callo-
sum, were analyzed by the patch-clamp technique (Fig. 6).
Cells were clamped at a potential of 270 mV and mem-
brane currents were activated by a series of de- and hyper-
polarizing voltage steps ranging from 2160 to 120 mV. All
cells investigated (n 5 6) displayed the same pattern of
s of reproduction in any form reserved.
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267GFP-Labeled Differentiated Oligodendrocytessymmetrical, passive, inward, and outward membrane cur-
rents carried by potassium (Fig. 6, right columns). Currents
were slightly inactivating due to a shift in the Nernst
potential during the voltage step. This type of current, also
designated leak conductance, was shown previously to be
characteristic of terminally differentiated, mature, O1
antigen-positive oligodendrocytes by in vitro (Barres, 1991;
ontheimer et al., 1989) and in situ investigations (Berger et
l., 1991; Kirchhoff et al., 1997). In contrast, oligodendro-
yte progenitor cells express predominantly voltage-gated,
elayed outward-rectifying potassium currents. In order to
etermine whether GFP-positive cells in all brain areas
isplay current characteristics of the more mature stages of
he oligodendrocyte lineage, we analyzed the potassium
urrent properties of GFP-positive cells in areas other than
he corpus callosum, such as cortex, striatum, and hip-
FIG. 4. Visualization of GFP-positive cells (GFP in A and B) and G
in A), and -PLP (PLP in B) double-positive cells in Vibratome sec
PLP-GFP mice using confocal imaging techniques. In (A), a region
(p, pyramidal cells of the hippocampal formation; so, stratum or
double-positive cells could be detected. No GFP-GFAP or GFP-Neu
oligodendrocytes. In (B), a typical area at the leading edge of myeli
were immunostained with PLP-specific antibodies in combinatio
displayed on the left with laser excitation at 488 nm (GFP) and on
analyzed were also positive for PLP. Arrows on the left (GFP) and
located in an area that contains a significant number of DM20-pos
FIG. 5. Visualization of GFP-positive cells in whole mounts of op
mice. Nerves were analyzed using a photomicroscope. Optic nerves
to the retina on the right. Scale bar, 100 mm.al., 1997). Scale bars, 100 mm.
Copyright © 2000 by Academic Press. All rightocampus. In animals as young as postnatal day 9, all
FP-positive cells analyzed (n 5 32) had lost mainly their
oltage-gated, outward-rectifying potassium currents and
isplayed a symmetrical in- and outward potassium conduc-
ance (F. Kirchhoff and C. Schipke, unpublished observa-
ions). Therefore, we concluded that in the CNS of 9-day- to
-week-old PLP-GFP mice GFP-positive cells display potas-
ium current characteristics of mature oligodendrocytes.
Since GFP expression was visible only in cell bodies (Fig.
, GFP, and Fig. 3), clamped cells were filled with the
uorescent dye Lucifer yellow to allow better morphologi-
al analysis of these cells. Using Lucifer yellow it was
reviously shown that small numbers of oligodendrocytes
re dye coupled and that dye coupling occurs at contacts
etween adjacent cell bodies (Butt and Ransom, 1993). In
ur experiments, we only rarely observed pairs of adjacent
C1 (GFP/CC1 in A), -GFAP (GFP/GFAP in A), -NeuN (GFP/NeuN
of brains from 23-day-old (in A) and 14-day-old (in B) transgenic
e white matter tract (wm) surrounding the hippocampus is shown
of the hippocampal formation; c, cortical layers). Only CC1-GFP
ble-positive cells were seen, indicating that GFP specifically labels
n in the cortex of a 14-day-old PLP-GFP mouse is shown. Sections
th Texas red-coupled secondary antibodies. The same section is
right with laser excitation at 568 nm (PLP). All GFP-positive cells
(PLP) indicate two typical GFP/PLP double-positive cells that are
, but PLP-negative, premyelinating oligodendrocytes (see Trapp et
erves from 6-day-old (P6) and 32-day-old (P32) transgenic PLP-GFP
oriented with the end close to chiasm on the left and the end closeFP-C
tions
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268 Fuss et al.cell bodies that were coupled. However, since we were
focusing on the display of the morphological characteristics
of the GFP-positive oligodendrocytes, we did not optimize
our experimental conditions for the display of gap junc-
tions. For all cells analyzed, parallel-oriented processes,
which are typical of axon-ensheathing oligodendrocytes,
became clearly visible with Lucifer yellow. These data
further confirmed the differentiated and myelinating stage
of the GFP-positive oligodendrocytes (Fig. 6, LY). No astro-
cytes, which are characterized by numerous fine, highly
branched, irregularly oriented processes, were patched al-
though they are present at a similar density (Fig. 4, GFP/
GFAP). Most importantly, these initial analyses clearly
demonstrated that brain slices obtained from transgenic
PLP-GFP mice are ideally suited for comprehensive physi-
ological characterization of differentiated oligodendrocytes
in situ.
GFP-Positive Oligodendrocytes in Culture Possess
a Mature Phenotype
After establishing that GFP expression in the postnatal
FIG. 6. Patch-clamp analysis of GFP-positive cells in corpus call
PLP-GFP mice and whole-cell membrane currents were investiga
GFP-positive cells selected for patch-clamp analysis are marked wit
(LY) visualized parallel-oriented processes that are characteristic
Activation of membrane currents by a series of de- and hyperpola
inward, and outward currents dominating the membrane conducta(9-day- to 7-week-old) CNS of transgenic PLP-GFP mice is
Copyright © 2000 by Academic Press. All rightestricted to mature oligodendrocytes, we developed a pro-
ocol for isolation and culture of in vivo-differentiated
ligodendrocytes for further analysis of their functional
roperties. First, we scanned enzymatically dissociated
ells from spinal cords (Fig. 7) and brains (not shown) of 3-
o 4-week-old transgenic and wild-type mice by analytical
ow cytometry. For better analysis, debris and erythrocytes
ere excluded by adjusting forward and side light scatter
ates. In order to confirm the identity of sorted GFP-
ositive cells as oligodendrocytes, cell suspensions were
mmunostained with the monoclonal antibody O4. The O4
ntibody recognizes a cell surface antigen that appears at an
ntermediate stage of oligodendroglial development, when
he cell is fully committed to terminal oligodendrocyte
ifferentiation, and that remains present when the cells
ature (Pfeiffer et al., 1993; Warrington and Pfeiffer, 1992).
Approximately 30% of the cells analyzed were O4-positive
in cell suspensions derived from spinal cords, whereas
preparations from brain contained only approximately 10%
O4-positive cells in cell populations analyzed under similar
conditions (data not shown). In cell preparations from
transgenic spinal cords, approximately two thirds of the
slices. 150-mm slices were obtained from 7-week-old transgenic
he top and bottom are recordings from two representative cells.
ite arrows (GFP). Dialysis of the selected cells with Lucifer yellow
mature oligodendrocytes after myelination of axonal processes.
g voltage steps (2160 to 120 mV) revealed symmetrical, passive,
(right column). Scale bars, 10 mm.osum
ted. T
h wh
of
rizinO4-positive cells were also GFP-positive and almost all of
s of reproduction in any form reserved.
v
d
G
p
q
d
h
p
u
fl
r
b
o
d
r
d
g
c
o
i
s
c
o
b
d
f
G
m
c
m
8
c
d
v
t
m
o
t
fl
269GFP-Labeled Differentiated Oligodendrocytesthe GFP-positive cells were O4-positive (Fig. 7, right plot).
These data suggested that fluorescence-activated cell sort-
ing is likely to yield highly pure cell preparations of in
ivo-differentiated oligodendrocytes from cell suspensions
erived from the CNS of 3- to 4-week-old transgenic PLP-
FP mice. The appearance of approximately 4.5% GFP-
ositive/O4-negative cells (Fig. 7, right plot, lower right
uadrant) may result from a loss of the O4 surface antigen
uring cell dissociation or it might reflect oligodendrocyte
eterogeneity, the existence of which has been suggested
reviously (Fanarraga and Milward, 1997).
In order to purify GFP-positive cells in larger quantity, we
sed combined suspensions of spinal cord and brain cells for
uorescence-activated cell sorting. Prior to sorting, eryth-
ocytes and debris were removed from the cell suspensions
y centrifugation through a density gradient. In order to
btain highly pure populations of GFP-positive oligoden-
rocytes, cells were considered positive only if their fluo-
escence was brighter than 99% of control cells, which were
erived from the CNS of age- and strain-matched nontrans-
enic mice. By these criteria approximately 5% of the live
ells were isolated as GFP-positive in vivo-differentiated
ligodendrocytes (Fig. 8A). When these cells were cultured
n defined medium or in medium containing FCS, all of the
urviving cells were GFP and GC positive after 48 h in
ulture. These cells, however, remained round in morphol-
gy with no obvious processes (data not shown). Since it has
een shown that survival and differentiation of oligoden-
rocyte progenitor cells is regulated by astrocyte-derived
actors (Barres and Raff, 1994), we cultured the purified
FP-positive cells in the presence of astrocyte-conditioned
edium. After 48 h, approximately 10% of the surviving
FIG. 7. FACS analysis of the distribution of O4-positive and GFP-p
ransgenic PLP-GFP mice (1/1) and wild-type mice (2/2). Two-c
uorescence intensity for GFP (x axis, logarithmic scale) and O4 (y
than 1% of the control cells were positive. Values of the percentag
cells (middle plot; upper left quadrant) and in cell suspensions fro
(right plot; upper left quadrant), as well as for O4/GFP double-positi
plot; lower right quadrant) cells.ells began to develop a more complicated morphology with
Copyright © 2000 by Academic Press. All rightultiple processes and myelin sheath-like structures (Fig.
B), a phenotype often described for mature oligodendro-
ytes in culture (Pfeiffer et al., 1993). In conclusion, these
ata indicate that the culture system described above pro-
ides a suitable tool for the characterization of yet uniden-
ified factors which may be required for survival/
aturation of in vivo terminally differentiated
ligodendrocytes.
DISCUSSION
The current studies describe the generation and charac-
terization of transgenic mice that express GFP under the
control of the PLP promoter. In the CNS of these mice, cells
fluorescently labeled by their GFP expression could be
clearly identified as mature oligodendrocytes by immuno-
cytochemical studies, by the spatiotemporal expression
pattern of the transgene in the optic nerve, and by electro-
physiological potassium current analysis of corpus callo-
sum slices. Furthermore, we demonstrated that differenti-
ated oligodendrocytes could easily be visualized in live, as
well as fixed, tissue, both from actively myelinating and
from adult (7-week-old) animals. This convenient localiza-
tion provided an expedient approach to electrophysiological
characterization of highly differentiated oligodendrocytes
in situ. In addition, we introduced a novel purification and
tissue culture system for in vivo-differentiated oligodendro-
cytes that now permits a detailed analysis of their molecu-
lar and cell biological features.
In the PLP-GFP mice, developmental and tissue-specific
expression of the transgenic GFP mRNA appears to be
ve cells in cell suspensions derived from spinal cords of 3-week-old
dot plot displays show the distribution of live cells according to
, logarithmic scale). Lines represent thresholds beyond which less
otal live cells are given in control cell suspensions for O4-positive
nsgenic PLP-GFP spinal cords for O4-positive/GFP-negative cells
ght plot; upper right quadrant) and GFP-positive/O4-negative (rightositi
olor
axis
e of t
m tra
ve (rientirely regulated by the PLP-derived promoter sequences.
s of reproduction in any form reserved.
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270 Fuss et al.However, levels of GFP mRNA were lower than of endog-
enous PLP mRNA, and, in contrast to the PLP mRNA, a
decrease in GFP mRNA from postnatal day 21 to 32 was
noticeable. Despite this reduction in mRNA levels, how-
ever, differentiated oligodendrocytes could easily be identi-
fied in the adult CNS by their GFP-derived fluorescence,
indicating robust protein expression. The discrepancy be-
tween levels of endogenous PLP mRNA and transgenic, PLP
promoter-driven mRNA is not unique to the transgenic line
described here, but was also found for three independent
lines of PLP-LacZ mice (Wight et al., 1993). In the CNS, the
transcription rate of the PLP gene decreases after postnatal
day 25 (Macklin et al., 1991), while endogenous PLP mRNA
levels remain high. The presence of putative mRNA-
stabilizing elements in the 39 untranslated region may
FIG. 8. Purification and culture of GFP-positive oligodendrocytes
y flow cytometry. The single-parameter fluorescence histogram in
A) shows the distribution of live cells according to their fluores-
ence intensity for GFP (x axis, logarithmic scale). Cell numbers
re plotted on the y-axis. The distribution of cells derived from
pinal cords and brains of transgenic PLP-GFP mice is delineated as
solid line and from control animals as a dotted line. Cells within
he area marked by the bar were considered GFP positive (5% of
otal live cells) and collected. Purified oligodendrocytes in culture
eveloped an appearance of myelinogenic oligodendrocytes 48 h
fter plating only in the presence of astrocyte-conditioned medium.
ithout the astrocyte conditioned medium, attached cells re-
ained round without processes. In (B) the same field is shown
nder laser excitation at 488 nm (for GFP) and at 568 nm (for
C/Texas red). All surviving cells were GFP and GC positive. Cells
ortrayed here were grown in astrocyte-conditioned DMEM/FCS
hat was supplemented with DMEM/N2/T3 24 h after plating.xplain the continued high levels of endogenous PLP l
Copyright © 2000 by Academic Press. All rightRNA in the adult CNS (Wight et al., 1993; B. Mallon and
. B. Macklin, unpublished observations). Consequently,
ithout the PLP-specific 39 sequences, transgenic GFP
RNA levels may more closely correlate with the tran-
cription rate of the PLP gene and decrease with lower rates
f transcription. In addition, in the transgenic PLP-GFP
ice, a genomic poly(A) signal, derived from the insertion
ite, seems to be utilized for GFP termination, which could
ontain mRNA-destabilizing elements. Nonetheless, the
evelopmental and tissue-specific expression of the trans-
enic GFP mRNA appears to be entirely regulated by
LP-derived sequences. These data are consistent with
ecent findings that despite the random insertion of trans-
enes into the genomic DNA, local effects appear to have
inimal impact on the transgene’s expression in those cells
hat initiate transcription (Graubert et al., 1998). Further-
ore, the absence of any obvious pathology in the trans-
enic PLP-GFP mice indicates that transgene integration
oes not interfere with the expression of endogenously
xpressed genes.
While the studies described here were focused on the
xpression of GFP in the CNS, it is noteworthy to mention
hat PLP-driven GFP mRNA and endogenously expressed
LP mRNA were additionally detected in the testis. Simi-
arly, testis expression was demonstrated for the
ligodendrocyte-derived proteins 29,39-cyclic nucleotide 39-
hosphodiesterase (Gravel et al., 1998) and oligodendro-
yte-specific protein (OSP/Claudin-11; Morita et al., 1999).
his shared expression of certain proteins might be attrib-
ted to structural similarities between oligodendrocytes in
he CNS and Sertoli cells in the testis, as was recently
uggested by Morita et al. (1999).
The presence of in situ-labeled mature oligodendrocytes
llowed us for the first time to distinguish unequivocally in
ivo-differentiated oligodendrocytes in the postnatal CNS
rom other neighboring glial cells such as astrocytes and
rogenitor cells prior to patch-clamp analyses. Therefore,
e were able to record current characteristics from highly
ifferentiated oligodendrocytes such as those present in the
orpus callosum of 7-week-old mice. Studies like this are of
articular advantage for a comparative analysis of oligoden-
rocyte physiology in gray and white matter, to assess, for
xample, whether oligodendrocytes that reside in gray mat-
er areas might represent a subpopulation of oligodendro-
lial cells with novel, region-specific electrophysiological
roperties. The usefulness of cell-specific GFP expression
or electrophysiological analyses is supported by recent
tudies identifying genetically modified DRG neurons after
ransfection with an adenovirus construct and demonstrat-
ng that the GFP label does not change the electrophysio-
ogical properties of the transfected cells (Smith et al.,
997). Thus, the PLP-GFP mice will likely facilitate many
hysiological studies of differentiated oligodendrocytes in
itu.
To permit more detailed cell biological analyses of in
ivo-differentiated oligodendrocytes under easily manipu-
able conditions, we developed a protocol for isolation and
s of reproduction in any form reserved.
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271GFP-Labeled Differentiated Oligodendrocytesculture of in vivo-differentiated, GFP-expressing oligoden-
rocytes. In order to estimate the percentage of GFP-
ositive cells that were isolated by this procedure, we
eferred to the following observations. The total number of
4-positive oligodendrocytes in the CNS was shown to
ncrease from birth to postnatal day 5 when it reaches a
lateau (Gard and Pfeiffer, 1989). For the telencephalon of a
-day-old rat the presence of 1.5 3 106 O4-positive oligo-
endrocytes was estimated (Gard and Pfeiffer, 1989), while
or a 7-day-old mouse cerebellum 1.5 3 105 O4-positive
ells were calculated (Meier et al., 1982). Furthermore, in
our experiments approximately 65% of O4-positive oligo-
dendrocytes appeared to be GFP positive. However, previ-
ously described data, using O4-positive cells from postnatal
day 13 rat cerebrum, indicated that only 40% of the
O4-positive cells represent mature oligodendrocytes (Shinar
and McMorris, 1995). The increased percentage of O4-
positive cells that would be defined as mature by their GFP
expression in our studies appears reasonable, since CNS
tissue from older animals, including spinal cord, was used.
Therefore, assuming that a 3- to 4-week-old mouse CNS
contains approximately 1.5 3 106 O4-positive oligodendro-
cytes, of which two-thirds are GFP positive, a recovery of
approximately 1% was achieved by the isolation of approxi-
mately 1 3 104 live GFP-positive cells per animal. Yields
this low have been described previously for the isolation of
differentiating oligodendrocytes from animals beyond post-
natal day 5 (Gard and Pfeiffer, 1989) and are likely to reflect
the difficulties in isolating living oligodendrocytes that
have already established a complex morphology. Higher
yields were described for the isolation from spinal cord
(Wood and Bunge, 1991), which is consistent with our
observations. Given the estimated low recovery rates, how-
ever, we cannot exclude that, under the conditions used,
preferentially a certain subpopulation of in vivo-
differentiated oligodendrocytes was isolated. Nevertheless
and more importantly, the culture system introduced here
provides a unique and novel system for a detailed analysis
of the environmental requirements for survival and matu-
ration of oligodendrocytes that developed in situ to a stage
at which they are terminally differentiated and begin to
myelinate axons.
Oligodendrocyte development and myelination are regu-
lated partially by intrinsic mechanisms, but are also signifi-
cantly influenced by signals derived from other cell types,
such as astrocytes and neurons (Barres and Raff, 1994). In
this context, it is noteworthy that after isolation by flow
cytometry, the ability to culture GFP-positive oligodendro-
cytes with a process-bearing, mature phenotype was criti-
cally dependent upon factors released by astrocytes. In
other studies, it has been demonstrated that survival of
cells at the different stages of oligodendrocyte differentia-
tion requires different growth factors. For example, combi-
nations of known astrocyte-derived molecules are appar-
ently sufficient for survival of oligodendrocyte progenitor
cells (Barres et al., 1993), whereas for survival of immuno-
panned, newly differentiated oligodendrocytes, an addi-
Copyright © 2000 by Academic Press. All rightional leukemia inhibitory factor-like protein appears to be
ssential (Gard et al., 1995). Therefore, differentiated oligo-
endrocytes of the mature CNS, such as the GFP-positive
ells used in our studies, may need yet unidentified envi-
onmental factors for survival and/or for the maintenance
f a myelinogenic state. Our data focus primarily on the
equirement for astrocyte-derived factors in order for ma-
ure cells to reestablish a process-bearing phenotype in
ulture. Thus, our data may suggest that astrocyte-derived
ignals might be involved in the formation of myelin
heath-like structures in vitro and possibly, in addition to
euron-derived components (Barres and Raff, 1993; Whitte-
ore et al., 1993), in the formation of the myelin sheath
tself. The importance of an interaction between oligoden-
rocytes and astrocytes for the formation of the myelin
heath is supported by data obtained in model systems of
emyelination and injury (Blakemore, 1984; Franklin et al.,
991). Furthermore, a link between astrocyte function and
he maintenance of the myelin sheath is suggested by a
ate-onset defect of myelination homeostasis in GFAP 2/2
nimals (Liedtke et al., 1996). However, it remains to be
elucidated whether, and which, soluble astrocyte-derived
factors regulate survival and/or the myelinogenic capacity
of differentiated oligodendrocytes.
For the most part, current literature about the functional
regulation of differentiated oligodendrocytes remains con-
fusing. Much of the data focus on myelin gene expression
by neonatal oligodendrocytes in culture, and integration of
the published data on differentiating oligodendrocytes is
complicated by differences in species, culture conditions,
and antibody specificities. Furthermore, it cannot be ex-
cluded that remyelination by cells that have undergone
myelination in situ requires different environmental clues
than myelination during development. For example, Lud-
win and Szuchet (1993) demonstrated that adult ovine
oligodendrocytes in culture do not myelinate dorsal root
ganglion neurons, whereas neonatal rodent oligodendro-
cytes do (Wood and Bunge, 1991). Additionally, Ladiwala et
al. (1998) demonstrated that NGF does not induce apoptosis
in adult human oligodendrocytes, whereas neonatal rodent
oligodendrocytes were shown to undergo NGF-induced
apoptosis (Casaccia-Bonnefil et al., 1996).
Thus, an evaluation of the functional properties of ma-
ture oligodendrocytes in situ and of their myelinating/
remyelinating capabilities could provide clarifying data
about the different mechanisms that may be involved in the
formation of the myelin sheath during normal development
and in remyelination of demyelinated axons under patho-
logical conditions. Analyses such as these have the poten-
tial to vastly improve strategies for enhanced remyelination
during CNS repair.
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